Navigation Links
Blood-Incompatible Heart Transplants Safe for Infants
Date:11/5/2007

Study data shows mortality could be reduced 20% for those awaiting new organ

MONDAY, Nov. 5 (HealthDay News) -- Blood group-incompatible heart transplants can safely be performed in infants age 1 year or younger and could help reduce death rates among infants with heart problems, say U.S. researchers.

Of 591 cases examined from national data reported to the United Network for Organ Sharing (UNOS)from 1999 to 2007, 35 infants (6 percent) received hearts from blood-group incompatible donors.

"There was no difference in outcome between incompatible and compatible transplantation in these infants. Survival between the two groups was similar (75 percent) at three years," senior study author Dr. Luca A. Vricella, chief of pediatric heart transplantation at Johns Hopkins Medical Institutions in Baltimore, said in a prepared statement.

Using blood-group incompatible donor hearts could significantly reduce the number of infants who die while waiting for a new heart. Babies under the age of 12 months have immature immune systems that are less likely to attack a donated heart, the researchers explained.

"Mortality could be reduced by at least 20 percent using incompatible donors. There would be a huge impact on infants who otherwise have to rely on a very small donor pool," Vricella said.

Currently, the average wait for a new infant heart is more than two months, and up to 40 percent of infants die before they receive a donor heart.

The study was to be presented Monday at the American Heart Association annual meeting in Orlando, Fla.

More information

The American Heart Association has more about heart transplants in infants and children.



-- Robert Preidt



SOURCE: Nov. 5, 2007, presentation, American Heart Association annual meeting, Orlando, Fla.


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Blood-incompatible infant heart transplants safe, may save more lives
2. Drug for cluster headaches may cause heart problems
3. Use of certain lipid measures not more effective in predicting coronary heart disease
4. Restricting Blood Flow May Help Heart Bypass Patients
5. Urban Smog Tough on Young Adults Hearts
6. Stanford study highlights cost-effective method of lowering heart disease risks
7. Vitamin Es lack of heart benefit linked to dosage
8. Drug That Lowers Resting Heart Rate Being Tested
9. Heart Attack Boosts Diabetes Risk
10. Embryonic Stem Cells Repair Human Heart
11. U of M study: Early treatment can reverse heart damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 2016 , ... TeaZa® Energy, LLC announces the launch of a ... Tobacco Day . The new flavor—Tropical TeaZa? Energy—will be available to customers exclusively ... The new flavor is best described as a juicy, taste bud takeover. A ...
(Date:5/31/2016)... Penn. (PRWEB) , ... May 31, 2016 , ... ... skills to apply information technology solutions to the healthcare industry, The University of ... graduate-level program offers an accelerated path to a career in rapidly growing field ...
(Date:5/30/2016)... ... May 30, 2016 , ... Zane Benefits, the ... of an original infographic, " Health Benefits Reimbursement Compliance Timeline ." , ... Benefits complies with various federal regulations and reforms. , Navigating the new health ...
(Date:5/29/2016)... (PRWEB) , ... May 29, 2016 , ... "With 30 ... let's the user control the style of their project," said Christina Austin - CEO ... 30 self-animating web-themed intros created exclusively for use in Final Cut Pro X. Pixel ...
(Date:5/28/2016)... ... ... city where’s it’s easy to spot the neon lights of chains serving fast food, one ... a taste for real food. , On May 13, the Best Western Plus ... restaurant focusing on dishes made by hand with wholesome, organic ingredients that are sourced locally ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
(Date:5/26/2016)... Since its commercial introduction in ... life science tool for conducting genetic studies in a ... in its new report that the industry sits on ... by a range of new applications in the clinical ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Since the Human ...
Breaking Medicine Technology: